Category: checkpoint inhibitor

  • TIGIT Therapies 2021

    Arriving at a critical point for TIGIT development, the 2nd Annual TIGIT Therapies Summit is the definitive industry-led event focused on propelling this next-generation inhibitor to clinical use. Enable TIGIT therapies to reach full clinical potential through uniting with 25+ TIGIT experts to discuss: • Refining Fc receptor co-engagement to inform effective drug design • […]